Two dissimilar AT1 agonists distinctively activate AT1 receptors located on the luminal membrane of coronary endothelium
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Diverse intracoronary agonists cause cardiac effects while acting on coronary endothelial luminal membrane (CELM) receptor. Our data show: a) the presence of AT1R in isolated CELM and in all cardiac cell types and b) sustained intracoronary infusions of Ang II-POL, a large sized molecule (~ 15,000 kDa) confined to the vessel lumen that can only act on CELM%27s AT1R or Ang II (~ 1 kDa); both exert the same maximum positive inotropic (PIE) and coronary constriction (CPP). The effects of these two agonists are blocked by Losartan and by Sar-POL; a large size antagonist (~ 15,000 kDa) that acts only on CELM. Ang II effects are transient due to desensitization and cause tachyphylaxis to Ang II and toward Ang II-POL suggesting that both Ang II and Ang II-POL act on the same receptor group. In contrast, Ang II-POL effects are sustained and do not cause tachyphylaxis. The results show that intravascular Ang II and Ang II-POL act differentially by an unknown mechanism on CELM%27s AT1R and suggest that intravascular Ang II and Ang II-POL cause PIE and CCP by activation limited to CELM%27s AT1R through an unknown mechanism that is space-confined to the CELM%27s AT1R. © 2009 Elsevier Inc. All rights reserved.
-
Diverse intracoronary agonists cause cardiac effects while acting on coronary endothelial luminal membrane (CELM) receptor. Our data show: a) the presence of AT1R in isolated CELM and in all cardiac cell types and b) sustained intracoronary infusions of Ang II-POL, a large sized molecule (~ 15,000 kDa) confined to the vessel lumen that can only act on CELM's AT1R or Ang II (~ 1 kDa); both exert the same maximum positive inotropic (PIE) and coronary constriction (CPP). The effects of these two agonists are blocked by Losartan and by Sar-POL; a large size antagonist (~ 15,000 kDa) that acts only on CELM. Ang II effects are transient due to desensitization and cause tachyphylaxis to Ang II and toward Ang II-POL suggesting that both Ang II and Ang II-POL act on the same receptor group. In contrast, Ang II-POL effects are sustained and do not cause tachyphylaxis. The results show that intravascular Ang II and Ang II-POL act differentially by an unknown mechanism on CELM's AT1R and suggest that intravascular Ang II and Ang II-POL cause PIE and CCP by activation limited to CELM's AT1R through an unknown mechanism that is space-confined to the CELM's AT1R. © 2009 Elsevier Inc. All rights reserved.
publication date
funding provided via
published in
Research
keywords
-
AT1R activation without desensitization; Compartmentalization of hormone action; Desensitization; Endothelial luminal AT1 receptors; Tachyphylaxis 1 (4 dimethylamino 3 methylbenzyl) 5 diphenylacetyl 4,5,6,7 tetrahydro 1h imidazo[4,5 c]pyridine 6 carboxylic acid; angiotensin 1 receptor; angiotensin II; angiotensin II polymer; losartan; unclassified drug; animal tissue; article; cell type; controlled study; coronary artery blood flow; coronary artery constriction; desensitization; drug mechanism; endothelium cell; heart muscle cell; intracoronary infusion; nonhuman; priority journal; protein localization; protein polymerization; rat; tachyphylaxis; vascular endothelium; Angiotensin II; Animals; Coronary Vessels; Endothelium, Vascular; Losartan; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Saralasin; Vasoconstriction
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue